These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29685497)

  • 1. Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants.
    Nadkarni GN; Chauhan K; Verghese DA; Parikh CR; Do R; Horowitz CR; Bottinger EP; Coca SG
    Kidney Int; 2018 Jun; 93(6):1409-1416. PubMed ID: 29685497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.
    Freedman BI; Langefeld CD; Turner J; Núñez M; High KP; Spainhour M; Hicks PJ; Bowden DW; Reeves-Daniel AM; Murea M; Rocco MV; Divers J
    Kidney Int; 2012 Oct; 82(7):805-11. PubMed ID: 22695330
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Chen TK; Tin A; Peralta CA; Appel LJ; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
    Clin J Am Soc Nephrol; 2017 Nov; 12(11):1771-1777. PubMed ID: 29051146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOL1 risk variants, race, and progression of chronic kidney disease.
    Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
    N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of Kidney Function Decline Associated with APOL1 Genotypes: Results from AASK.
    Tin A; Grams ME; Estrella M; Lipkowitz M; Greene TH; Kao WHL; Li L; Appel LJ
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1353-1359. PubMed ID: 27230965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Schrauben SJ; Shou H; Zhang X; Anderson AH; Bonventre JV; Chen J; Coca S; Furth SL; Greenberg JH; Gutierrez OM; Ix JH; Lash JP; Parikh CR; Rebholz CM; Sabbisetti V; Sarnak MJ; Shlipak MG; Waikar SS; Kimmel PL; Vasan RS; Feldman HI; Schelling JR;
    J Am Soc Nephrol; 2021 Jan; 32(1):115-126. PubMed ID: 33122288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial Validation of a Machine Learning-Derived Prognostic Test (KidneyIntelX) Integrating Biomarkers and Electronic Health Record Data To Predict Longitudinal Kidney Outcomes.
    Chauhan K; Nadkarni GN; Fleming F; McCullough J; He CJ; Quackenbush J; Murphy B; Donovan MJ; Coca SG; Bonventre JV
    Kidney360; 2020 Aug; 1(8):731-739. PubMed ID: 35372952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV.
    Jotwani V; Shlipak MG; Scherzer R; Parekh RS; Kao WH; Bennett M; Cohen MH; Nowicki M; Sharma A; Young M; Tien PC; Parikh CR; Estrella MM
    Am J Kidney Dis; 2015 Jun; 65(6):889-98. PubMed ID: 25921719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race, APOL1 Risk Variants, and Clinical Outcomes among Older Adults: The ARIC Study.
    Chen TK; Coresh J; Daya N; Ballew SH; Tin A; Crews DC; Grams ME
    J Am Geriatr Soc; 2021 Jan; 69(1):155-163. PubMed ID: 32894582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
    Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Chen TK; Appel LJ; Grams ME; Tin A; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1765-1769. PubMed ID: 28572159
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Doshi MD; Ortigosa-Goggins M; Garg AX; Li L; Poggio ED; Winkler CA; Kopp JB
    J Am Soc Nephrol; 2018 Apr; 29(4):1309-1316. PubMed ID: 29339549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOL1 Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19 From the Million Veteran Program.
    Hung AM; Shah SC; Bick AG; Yu Z; Chen HC; Hunt CM; Wendt F; Wilson O; Greevy RA; Chung CP; Suzuki A; Ho YL; Akwo E; Polimanti R; Zhou J; Reaven P; Tsao PS; Gaziano JM; Huffman JE; Joseph J; Luoh SW; Iyengar S; Chang KM; Casas JP; Matheny ME; O'Donnell CJ; Cho K; Tao R; Susztak K; Robinson-Cohen C; Tuteja S; Siew ED;
    JAMA Intern Med; 2022 Apr; 182(4):386-395. PubMed ID: 35089317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
    Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP;
    Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.
    Pavkov ME; Nelson RG; Knowler WC; Cheng Y; Krolewski AS; Niewczas MA
    Kidney Int; 2015 Apr; 87(4):812-9. PubMed ID: 25272234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.
    Lipkowitz MS; Freedman BI; Langefeld CD; Comeau ME; Bowden DW; Kao WH; Astor BC; Bottinger EP; Iyengar SK; Klotman PE; Freedman RG; Zhang W; Parekh RS; Choi MJ; Nelson GW; Winkler CA; Kopp JB;
    Kidney Int; 2013 Jan; 83(1):114-20. PubMed ID: 22832513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.
    Coca SG; Nadkarni GN; Huang Y; Moledina DG; Rao V; Zhang J; Ferket B; Crowley ST; Fried LF; Parikh CR
    J Am Soc Nephrol; 2017 Sep; 28(9):2786-2793. PubMed ID: 28476763
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Chung CP; Karakoc G; Dickson A; Liu G; Gamboa JL; Mosley JD; Cox NJ; Kawai VK
    Lupus; 2023 May; 32(6):763-770. PubMed ID: 37105192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Genetic African Ancestry on eGFR and Kidney Disease.
    Udler MS; Nadkarni GN; Belbin G; Lotay V; Wyatt C; Gottesman O; Bottinger EP; Kenny EE; Peter I
    J Am Soc Nephrol; 2015 Jul; 26(7):1682-92. PubMed ID: 25349204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.
    Alderson HV; Ritchie JP; Pagano S; Middleton RJ; Pruijm M; Vuilleumier N; Kalra PA
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2141-2149. PubMed ID: 27852662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.